Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting MS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00306592
What this trial is testing

Natalizumab Re-Initiation of Dosing

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 404
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Testing effectiveness (Phase 2)UnknownNCT00151801
What this trial is testing

Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients

Who this might be right for
Multiple Sclerosis
S. Andrea Hospital 200
Not applicableStudy completedNCT01031459
What this trial is testing

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

Who this might be right for
Multiple Sclerosis
Bayer 176
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Not applicableStudy completedNCT06705608
What this trial is testing

Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study

Who this might be right for
Multiple SclerosisSkin CancerSkin Cancer Melanoma+3 more
University of British Columbia 4,000
Not applicableEnded earlyNCT01905527
What this trial is testing

Adherence Trial With MS LifeLines ® Services

Who this might be right for
Multiple SclerosisRelapsing-Remitting
EMD Serono 306
Not applicableEnded earlyNCT02218879
What this trial is testing

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

Who this might be right for
Multiple Sclerosis
Yale University 7
Not applicableStudy completedNCT06987994
What this trial is testing

The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingVirtual Reality
Istinye University 30
Testing effectiveness (Phase 2)Study completedNCT06812585
What this trial is testing

The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
German University in Cairo 30
Early research (Phase 1)Study completedNCT01244139
What this trial is testing

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 47
Not applicableUnknownNCT02769767
What this trial is testing

Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Instituto Jalisciense de Cancerologia 500
Not applicableStudy completedNCT01592097
What this trial is testing

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

Who this might be right for
Multiple Sclerosis
University of Southern California 51
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Testing effectiveness (Phase 2)Study completedNCT00382629
What this trial is testing

BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Bayhill Therapeutics 252
Not applicableStudy completedNCT01491100
What this trial is testing

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayer 1,085
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07263607
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
Sichuan Academy of Medical Sciences 80
Not applicableStudy completedNCT01848327
What this trial is testing

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

Who this might be right for
Relapsing Remitting MSSecondary Progressive MSPrimary Progressive MS
University of Miami 124
Post-approval studies (Phase 4)Study completedNCT02461069
What this trial is testing

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital Muenster 67
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Next Page